Terminated NA INTERVENTIONAL 2-arm NCT00833300

Haloperidol vs Olanzapine for the Management of ICU Delirium

Haloperidol vs Olanzapine for the Management of ICU Delirium: A Randomized Clinical Trial

Sponsor: Dalhousie University

Updated 6 times since 2017 Last updated: Aug 2, 2012 Started: Jun 30, 2008 Primary completion: Nov 30, 2011 Completion: Nov 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Dalhousie University

See all terminations from Dalhousie University

Other Agitation trials with similar outcome

Browse all Agitation trials

Listed as NCT00833300, this NA trial focuses on Agitation and Delirium and remains terminated or withdrawn. Sponsored by Dalhousie University, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Feb 2017 — Jun 2018 [monthly]

Terminated NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated NA

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dalhousie University
Richard Hall

Data source: Nova Scotia Health Authority

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Halifax, Canada